Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review

• Type: Another Publication in an International Scientific Journal
• Date: 2022

Authors

Von-Hafe, M (Author) Other; Borges-Canha, M (Author) FMUP; Vale, C (Author) FMUP; Leite, AR (Author) Other; Neves, JS (Author) FMUP; Carvalho, Davide (Author) FMUP; Leite-Moreira AF (Author) FMUP

Journal

Title: Metabolites

Vol. 12

Final page: 298

ISSN: 2218-1989

Publisher: MDPI

Indexing

ISI Web of Knowledge - 18 Citations

Scopus - 4 Citations

Other information

Authenticus ID: P-00W-AQX

DOI: 10.3390/metabo12040298

Abstract (EN): Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. NAFLD often occurs associated with endocrinopathies. Evidence suggests that endocrine dysfunction may play an important role in NAFLD development, progression, and severity. Our work aimed to explore and summarize the crosstalk between the liver and different endocrine organs, their hormones, and dysfunctions. For instance, our results show that hyperprolactinemia, hypercortisolemia, and polycystic ovary syndrome seem to worsen NAFLD's pathway. Hypothyroidism and low growth hormone levels also may contribute to NAFLD's progression, and a bidirectional association between hypercortisolism and hypogonadism and the NAFLD pathway looks likely, given the current evidence. Therefore, we concluded that it appears likely that there is a link between several endocrine disorders and NAFLD other than the typically known type 2 diabetes mellitus and metabolic syndrome (MS). Nevertheless, there is controversial and insufficient evidence in this area of knowledge.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 30